No abstract available
MeSH terms
-
Adolescent
-
Adult
-
Aza Compounds / adverse effects
-
Aza Compounds / therapeutic use
-
Bacterial Infections / diagnosis
-
Bacterial Infections / drug therapy
-
Blood Glucose / drug effects
-
Ciprofloxacin / adverse effects
-
Ciprofloxacin / therapeutic use
-
Dose-Response Relationship, Drug
-
Drug Administration Schedule
-
Drug Approval
-
Evidence-Based Medicine
-
Family Practice
-
Female
-
Fluoroquinolones / adverse effects*
-
Fluoroquinolones / therapeutic use
-
Gatifloxacin
-
Humans
-
Hyperglycemia / chemically induced*
-
Hyperglycemia / epidemiology
-
Hypoglycemia / chemically induced*
-
Hypoglycemia / epidemiology
-
Incidence
-
Male
-
Middle Aged
-
Moxifloxacin
-
Ofloxacin / adverse effects
-
Ofloxacin / therapeutic use
-
Quinolines / adverse effects
-
Quinolines / therapeutic use
-
Randomized Controlled Trials as Topic
-
Risk Assessment
-
United States
-
United States Food and Drug Administration
Substances
-
Aza Compounds
-
Blood Glucose
-
Fluoroquinolones
-
Quinolines
-
Ciprofloxacin
-
Ofloxacin
-
Gatifloxacin
-
Moxifloxacin